Here, we demonstrate that ascorbic acid acts as a nucleophile and forms Michaeltype conjugates with electrophilic LPO products. Several ascorbyl-LPO product conjugates, resulting from the interaction of ascorbic acid with hydroperoxy octadecadienoic acid in vitro, were identified by tandem MS, including ascorbyl conjugates of HNE, 4-oxo-2-nonenal, and presumably, 12-oxo-9-hydroxy-10-dodecenoic acid. The same ascorbyl-LPO product conjugates were detected in human plasma. The concentration of the ascorbyl-HNE conjugate in plasma from 11 healthy subjects was found to be 1.30 ؎ 0.74 M (mean ؎ SD). Our data identify ascorbylation (vitamin C conjugation) as a previously unrecognized, biologically relevant pathway for the elimination of electrophilic LPO products, and have implications for the prevention and treatment of chronic inflammatory diseases, as well as the development of novel biomarkers of oxidative stress.
hydroxynonenal ͉ mass spectrometry ͉ oxidative stress ͉ ascorbic acid ͉ biomarker U nder conditions of oxidative stress, unsaturated fatty acids may undergo lipid peroxidation (LPO), and subsequently form reactive aldehyde species that are both cytotoxic and genotoxic through their ability to covalently modify proteins and DNA (1, 2) . Furthermore, cellular damage and chronic inflammation observed in age-related disorders such as atherosclerosis and Alzheimer's disease may arise from LPO products (3) (4) (5) (6) (7) . For instance, oxidized phospholipids containing 8-oxo-5-hydroxy-6-octenoic acid and 12-oxo-9-hydroxy-10-dodecenoic acid in the sn-2 position are known proinflammatory mediators that may contribute to atherogenesis by activating endothelial cells and stimulating recruitment of monocytes to the arterial wall (8, 9) . Perhaps the best-known LPO product is 4-hydroxy-2-nonenal (HNE), which can form covalent adducts with 2Ј-deoxyguanosine (10, 11) , induce aggregation of low-density lipoproteins (12) (13) (14) (15) , and cause protein crosslinking (16) (17) (18) . The adduct of HNE with 2Ј-deoxyguanosine is strongly mutagenic by inducing G:C to T:A transversions in human cells (19) . HNE can also indirectly contribute to carcinogenesis by covalently binding to DNA-repair enzymes, which can lead to loss of nucleotide excision repair (20) .
Lipid hydroperoxides, specifically hydroperoxy octadecadienoic acids (HPODEs) may be formed enzymatically through the action of lipoxygenases (21, 22) or nonenzymatically through the reaction of linoleic acid with reactive oxygen species (23) . A key step in the generation of toxic LPO products is the formation of an alkoxy radical from the corresponding HPODE. The alkoxy radical can undergo ␣,␤-carbon-carbon bond cleavage, giving rise to a multitude of toxic LPO products, including HNE, 4-oxo-2-nonenal (ONE), and 4-hydroperoxy-2-nonenal (24) . HNE and other 4-hydroxy-2-alkenals can also be formed from arachidonic acid-derived hydroperoxides (24) . It is well known that HPODEs undergo transition metal ion-mediated decomposition, presumably through transfer of an electron, to give the alkoxy radical (25, 26) . Interestingly, Blair and coworkers (27) recently reported that vitamin C (ascorbic acid) also has the ability to act as an electron donor to HPODEs and, based on their data, suggested a possible toxic role for vitamin C as a promoter of LPO (27) .
In the present work, we confirm the ability of vitamin C to mediate the conversion of HPODE into HNE. However, we also demonstrate that ascorbic acid forms a conjugate with HNE by Michael addition, a two-electron reaction in which ascorbic acid plays the role of nucleophile. Therefore, vitamin C acts as an electron donor to HPODE, causing HNE formation, and subsequently acts as a detoxifying agent against HNE by functioning as a Michael donor (Scheme 1). In addition to the ascorbyl-HNE conjugate, we also show the formation of other LPO productascorbic acid conjugates. Finally, plasma from human subjects was found to contain the ascorbyl-LPO product conjugates, thereby confirming that vitamin C acts as a Michael donor in vivo.
Materials and Methods
Chromatography. Three liquid chromatography (LC) systems were used to separate ascorbyl-LPO product conjugates. LC system 1 used a C18 column (250 ϫ 1 mm, 4 m; Phenomenex, Torrance, CA) with a flow rate of 50 l͞min, interfaced directly with the mass spectrometer. Solvent A consisted of 10 mM ammonium acetate and 0.1% (vol͞vol) trifluoroacetic acid in nanopure water. Ammonium acetate was added to the solvent to aid in the ionization process because not all species analyzed were efficiently protonated. Solvent B was acetonitrile. A linear gradient of 25% solvent B to 85% solvent B over 45 min was used. LC system 2 was identical to LC system 1, with the exception being that an isocratic solvent system of 25% solvent B was used. A linear gradient of 5% solvent B to 75% solvent B over 20 min was used for LC system 3.
MS.
MS experiments were conducted on a PerkinElmer Sciex API III Plus triple quadrupole mass spectrometer equipped with an electrospray ion source (Concord, ON, Canada). The instrument was operated in positive ion mode with a discharge current Abbreviations: GSH, glutathione; HNE, 4-hydroxy-2-nonenal; HPODE, hydroperoxy octadecadienoic acid; LC, liquid chromatography; MRM, multiple-reaction monitoring; LC͞MS͞ MS-MRM, LC͞tandem MS using MRM; LPO, lipid peroxidation; ONE, 4-oxo-2-nonenal. of 5 A. Zero air was used as the sheath gas and nitrogen was used as the curtain gas. For collision-induced dissociation experiments, argon-nitrogen (9:1) was used as the collision gas, with a 15-eV collision energy. High-resolution MS experiments were conducted on a Micromass Q-TOF Global Ultima instrument (Milford, MA).
Analysis of Ascorbyl-LPO Product Conjugates in Human Plasma. Twohundred-microliter aliquots of blood plasma from three healthy subjects were mixed with formic acid (5 l), water (1.0 ml), and 0.1 N HCl (0.5 ml). The aqueous mixture was extracted with ethyl acetate (3 ϫ 3 ml), and the combined ethyl acetate layers were evaporated under a stream of nitrogen gas. The residues were redissolved in ethanol (65 l), and the ethanolic solution was mixed with LC solvent A (65 l) and centrifuged just before analysis. Aliquots (10 l) of the supernatants were taken and analyzed by using LC system 3, with the mass spectrometer operated in multiple-reaction monitoring (MRM) mode. A synthetic standard was used to compare chromatographic behavior. Blanks were run under identical conditions.
To ascertain that the observed results were not due to an ex vivo artifact, 200 l of plasma was spiked with 2.0 mg of isotopically labeled 13 C 6 -ascorbic acid (57 mM) and incubated for 2 h at 37°C. The sample was then acidified, extracted with ethyl acetate, dried under nitrogen, and reconstituted. Aliquots (10 l) were taken and analyzed by using LC system 3, with the mass spectrometer operating in MRM mode. The experiment was repeated with the exception being that isotopically labeled 13 C 6 -ascorbic acid was added immediately before acidification and extraction. The putative 13 C 6 -isotopomeric ascorbyl-LPO product conjugate was not detected in either case. Finally, plasma was incubated with 0.1 unit͞ml ascorbate oxidase for 20 min to remove endogenous ascorbic acid (28) . A control plasma sample was prepared in parallel, containing no ascorbate oxidase. The samples were acidified, extracted with ethyl acetate, dried under nitrogen, reconstituted, and analyzed by using LC system 3, with the mass spectrometer operating in MRM mode. The amount of ascorbyl-HNE was the same in both samples.
Quantification of Ascorbylated HNE in Plasma. The ascorbyl-HNE adduct (external standard) and the ascorbyl-octenal adduct (internal standard) were prepared as described in Supporting Materials and Methods, which is published as supporting information on the PNAS web site. Plasma samples from 11 healthy subjects were prepared as described above, with the exception being that they were spiked with internal standard (ascorbyloctenal adduct, 25 M final concentration) before extraction. Samples were analyzed by LC͞tandem MS using MRM (LC͞ MS͞MS-MRM) and the concentration of the ascorbyl-HNE conjugate was calculated from a calibration curve, constructed with the ascorbyl-octenal adduct as the internal standard and synthetic ascorbyl-HNE adduct (see above) as the analyte. Detector linearity (r 2 ϭ 0.996, n ϭ 7) was observed from 0.5 to 100 M.
A standard addition experiment was conducted to assess the accuracy of the analysis method. Aliquots (200 l) of a plasma sample were spiked with internal standard (25 M) and known amounts of the ascorbyl-HNE adduct to give concentrations of 1.0, 2.0, 4.0, and 6.0 M. The samples were then extracted and analyzed by LC͞MS͞MS-MRM, as described above.
All other experimental details are contained in Supporting Materials and Methods.
Results and Discussion
Ascorbic Acid as a Michael Donor. We hypothesized that vitamin C (ascorbic acid) plays a dual role in LPO processes: (i) as a one-electron donor to convert lipid hydroperoxides into their corresponding alkoxy radicals that subsequently decompose to a variety of electrophilic LPO products, including HNE (27) ; and (ii) as a two-electron donor to convert these electrophilic LPO products into their ascorbyl conjugates through Michael addition chemistry (Scheme 1). To test this hypothesis, we first investigated the capability of vitamin C to act as a Michael donor with LPO products. Ascorbic acid and HNE were allowed to react in chelex-treated 100 mM phosphate buffer (pH 7.4) at 37°C. Reaction products were monitored by using LC͞MS͞MS-MRM analysis. To aid in structural determinations, the reaction was carried out by using an equimolar mixture of unlabeled ascorbic acid and isotopically labeled 13 C 6 -ascorbic acid. The mass spectrum of the ascorbyl-HNE conjugate is shown in Fig. 1A . The expected m͞z values for the product (m͞z 333
were observed, as well as the peaks of the corresponding isotopomer (m͞z ϩ 6). To better characterize the ascorbyl-HNE conjugate, MS͞MS daughter scans were recorded for protonated products, both unlabeled and isotopically labeled ( Fig. 1 B and C, respectively) Fig. 6 , which is published as supporting information on the PNAS web site), supporting the notion that vitamin C acts as a Michael donor for ␣,␤-unsaturated aldehydes, and thus potentially eliminates the cytotoxic and genotoxic nature of these electrophilic LPO products.
Structure Elucidation of the Ascorbyl-HNE Adduct. The proposed structure of the ascorbyl-HNE adduct as presented in Scheme 1 and Fig. 1 was further supported by NMR analysis. The 1 H (400 MHz) and 13 C (100 MHz) NMR spectra, recorded in CD 3 OD, showed no aldehyde proton signals and only one carbonyl carbon (␦ C 174.3), indicating that the initial Michael adduct formed a tricyclic product by hemiketal͞hemiacetalization of the ascorbyl Scheme 1. Vitamin C as one-electron donor and Michael donor. Vitamin C may function as a one-electron donor to HPODE, thereby inducing formation of the alkoxy radical. The alkoxy radical then undergoes ␣,␤-carbon-carbon bond cleavage, generating HNE as well as other LPO products. As shown in this study, vitamin C may also function as a Michael donor and react with HNE and other LPO products, giving a variety of ascorbyl-LPO product conjugates.
and HNE moieties (Scheme 1). The facile cleavage of the ascorbyl-HNE linkage in the MS͞MS experiment argues against cross ketal͞acetalization between the ascorbyl and HNE moieties. The structure of the ascorbyl-HNE conjugate was thus determined to be 3,3␣,6-trihydroxy-3-(5-hydroxy-2-pentyltetrahydro-furan-3-yl)-tetrahydro-furo[3,2-b]furan-2-one (see Scheme 1 for atom numbering).
Two-dimensional NMR experiments, 1 H-1 H COSY and 1 H-13 C heteronuclear multiple quantum coherence, were conducted to obtain further evidence for the tricyclic structure of the ascorbyl-HNE adduct. The pentyl moiety was evident from a triplet at ␦ H 0.95 and a broad multiplet at ␦ H 1.36. In the heteronuclear multiple quantum coherence spectrum, the hemiacetal proton signal at ␦ H 5.82 (triplet) showed a cross peak with a carbon signal at ␦ C 102.7; these resonances and others (i.e., ␦ C 26.5͞␦ H 1.5-1.6 m, ␦ C 25.5͞␦ H 1.5-1.6 m, and ␦ C 70͞␦ H 4.05 m) were assigned to positions 5, 4, 3, and 2 of the HNE moiety, respectively, because the oxymethine proton at ␦ H 4.05 interacted with the methylene protons of the pentyl substituent and with the H-3 proton at ␦ H 1.5-1.6 in the COSY spectrum. The ascorbyl moiety showed signals for positions 2 (␦ C 174.3), 3 (␦ C 102.7), 3␣ (␦ C 106.7, hemiketal carbon), 5 (␦ C 72.5͞␦ H 3.85 m), 6 (␦ C 62.5͞␦ H 3.6-3.7 m), and 6␣ (␦ C 87.5͞␦ H 4.45 br s), which were mainly assigned on the basis of correlations observed in the heteronuclear multiple quantum coherence spectrum.
Whereas the two rings of the ascorbyl moiety can only be fused in a cis manner, Michael addition as depicted in Scheme 1 gives rise to diastereoisomerism due to the formation of new asymmetric centers at C-3 of the ascorbyl moiety, and at carbon atoms 2, 3, and 5 of the HNE moiety. Indeed, several unresolved peaks were observed upon LC͞MS analysis of the ascorbyl-HNE conjugate and other ascorbyl-LPO product conjugates, which is indicative of the formation of diastereoisomers. Similarly, multiple peak fractions showing prominent [MϩNH 4 ] ϩ ions with m͞z 350 were obtained by semipreparative HPLC isolation of ascorbylated HNE. The NMR spectra recorded for the main peak fraction showed a number of smaller resonances in addition to a series of main resonances, indicating the presence of one major isomer and a few minor isomers in the isolated material.
Another aspect of the ascorbylation reaction with 4-hydroxy-2-alkenals is the role of the ␥-hydroxy group in stabilizing the ascorbyl adduct. As shown in Scheme 1, the ␥-hydroxy group of HNE forms a stable cyclic hemiacetal with the aldehyde group, thus preventing enolization of the aldehyde, which would set the stage for a retro-Michael reaction and cleavage of the ascorbyl-HNE linkage. Thus, the ␥-hydroxy group of 4-hydroxy-2-alkenals appears to play an important role in the stabilization of ascorbyl adducts with these LPO products.
Interactions of HPODE with Ascorbic Acid and Glutathione (GSH).
Based on the results in Fig. 1 and the findings of Blair and coworkers (27) , we reasoned that vitamin C could initiate the decomposition of HPODEs to toxic LPO products and then react with these decomposition products, provided sufficient vitamin C remains (Scheme 1). HPODEs were decomposed by using various concentrations of ascorbic acid in chelex-treated 100 mM phosphate buffer (pH 7.4) at 37°C. LC͞MS͞MS-MRM analysis was used to identify HNE and the ascorbyl-HNE adduct. As shown in Fig. 2A , by using a 15-fold molar excess of vitamin C (3 mM) relative to HPODE (0.2 mM), HNE formation peaked at 15 min and subsequently decreased over time. During the decline in HNE, a concomitant increase of the ascorbyl-HNE conjugate was observed (Fig. 2B) . However, when the experiment was carried out by using approximately equimolar amounts of vitamin C and HPODE (0.3 and 0.2 mM, respectively), a steady state of HNE was observed and the ascorbyl-HNE conjugate was not detected (Fig. 2C) , presumably due to depletion of ascorbic acid by reaction with HPODE and other LPO products. These results suggest that HNE, produced by means of vitamin C-mediated decomposition of HPODEs, is readily consumed through Michael-type conjugation with available vitamin C. Because vitamin C concentrations far exceed HPODE concentrations in human tissues and in plasma, the data in Fig. 2 A and B are likely to be more relevant to the in vivo situation than the data in Fig. 2C , where ascorbate is depleted by interaction with HPODE. Nevertheless, the latter situation (Fig. 2C) could occur in microenvironments of tissues exposed to severe oxidative stress.
We also investigated the possibility of vitamin C reacting with other, lesser-known toxic LPO products. To this end, HPODE (0.2 mM) was degraded by using a 15-fold excess of vitamin C (3 mM), added as an equimolar mixture of isotopically labeled ( 13 C 6 ) and unlabeled ascorbic acid. The products of the reaction were monitored by LC͞MS. The use of an isotopic mixture of ascorbic acid aided in the identification of ascorbyl-LPO product conjugates. In addition to the ascorbyl-HNE conjugate, at least two other ascorbyl-LPO product conjugates were observed (Fig.  7 , which is published as supporting information on the PNAS web site). The lipid moieties of these conjugates were assigned the C 12 and C 13 oxylipid structures shown in Figs. 4 and 7 . The C 12 oxylipid was tentatively identified as the known HPODE degradation product, 12-oxo-9-hydroxy-10-dodecenoic acid (29, 30) . Recent autoxidation studies by Sun and Salomon (31) indicate that this C 12 oxylipid is formed from 13-HPODE with a yield of Ϸ2%, presumably through interconversion into 9-HPODE and subsequent oxygenation at position 12, followed by ␤-scission of the C 12 -C 13 bond, and reduction of the 9-hydroperoxy group. The C 13 oxylipid, tentatively characterized as 13-oxo-9,10-dihydroxy-11-tridecenoic acid, may have originated from the common 13-HPODE degradation product, 13-oxotrideca-9,11-dienoic acid (24), through 9,10-epoxidation and hydrolysis of the epoxide. Additionally, in an effort to better characterize the oxylipid component of the conjugates, HPODE (0.2 mM) was degraded with ferrous sulfate (0.2 mM) at 37°C for 2 h, and MS͞MS daughter scans were performed on the appropriate LPO products. The MS data, in conjunction with the literature reports, are in support of the tentative structural assignments.
The possibility that GSH, like ascorbic acid, may be capable of inducing the decomposition of HPODE was also investigated. An Ϸ15-fold molar excess of GSH (3.25 mM) was allowed to react with HPODE (0.2 mM) in chelex-treated 100 mM phosphate buffer (pH 7.4), and product formation was monitored by using LC͞MS͞MS-MRM analysis. Whereas free HNE was not detected, glutathionylated HNE was observed at all time points investigated (from 20 min to 15 h, data not shown). Additional glutathionylated LPO products were also observed and were analogous to the ascorbyl-LPO product conjugates found during vitamin C-mediated HPODE decomposition. These data indicate that GSH is capable of inducing the decomposition of HPODE. The lack of direct observation of HNE is likely due to fast reaction kinetics with GSH, i.e., HNE is scavenged by GSH immediately after its formation from HPODE.
It is known that ascorbic acid can have a prooxidant effect if trace amounts of iron or copper are present in the reaction mixture. To ensure that the above results were due to vitamin C-mediated decomposition of HPODE, as opposed to metal ion-mediated degradation, the reaction of HPODE (0.2 mM) with ascorbic acid (3 mM) was performed in the presence or absence of 1 mM diethylenetriaminepentaacetic acid, a known metal chelator. The results were not affected by diethylenetriaminepentaacetic acid, confirming the findings of Blair and coworkers (27) that vitamin C is responsible for HPODE decomposition, not trace metal ions. Furthermore, when the concentration of ascorbic acid was less than or equal to the concentration of HPODE, neither HNE nor the ascorbyl-HNE adduct was detected (data not shown). However, as the vitamin C concentration increased, formation of HNE, and subsequently the ascorbyl-HNE adduct, was observed (see Fig. 2 ). If vitamin C were functioning in a prooxidant capacity by recycling trace amounts of copper or iron, such changes in ascorbic acid concentration should not substantially alter product formation. Additionally, from a thermodynamic standpoint, GSH does not have the ability to reduce ferric to ferrous iron and therefore could not recycle iron ions (32) . Therefore, our data suggest that both ascorbic acid and GSH have the ability to decompose HPODE by direct one-electron transfer and subsequently scavenge the resultant LPO products through Michael addition.
Ascorbylated LPO Products in Human Plasma. Following the structural characterization of the ascorbyl-LPO product conjugates formed in vitro (Figs. 1, 6 , and 7), we analyzed plasma from three healthy subjects for the presence of ascorbyl conjugates. Human plasma samples were acidified and extracted with ethyl acetate as described in Materials and Methods. The extracts were analyzed by using LC͞MS͞MS-MRM and found to contain the ascorbyl-HNE conjugate (Fig. 3) . Three other ascorbyl-LPO product conjugates were detected in human plasma (Fig. 4) , the lipid masses of which were in agreement with ONE (data not shown) and the C 12 and C 13 oxylipid structures formed in vitro from HPODE and ascorbic acid. The ascorbyl conjugates of these LPO products were found in all three plasma samples, demonstrating that ascorbic acid functions as a biological nucleophile in vivo.
Once the presence of the ascorbyl-HNE conjugate in plasma was established, it was of interest to develop a method that would allow for quantitation of the conjugate. A calibration curve was constructed by using various concentrations (0.5-100 M) of the synthetic ascorbyl-HNE adduct mixed with a fixed concentration (25 M) of the internal standard, the ascorbyl-octenal adduct. The plasma samples were spiked with the internal standard before extraction and analyzed by using LC͞MS͞MS-MRM. The plasma concentration of the ascorbyl-HNE conjugate in 11 healthy subjects was found to be 1.30 Ϯ 0.74 M (mean Ϯ SD).
To assess the accuracy of our analysis method and to investigate the possibility of interfering matrix effects, a standard addition experiment was conducted. Aliquots of a plasma sample were spiked with both internal standard and various amounts of the synthetic ascorbyl-HNE adduct, and analyzed by using LC͞MS͞MS-MRM (Fig. 5, curve B) . Extrapolation to y ϭ 0 yielded an ascorbyl-HNE concentration of 2.28 M. A duplicate sample was prepared and analyzed by using the calibration curve A in Fig. 5 , which gave an ascorbyl-HNE concentration of 2.68 M. These results indicate that the extraction and quantitation steps used in the analysis method are accurate and reproducible.
The concentrations we determined for ascorbylated HNE in human plasma are much higher than the levels of well characterized LPO products. For instance, F 2 -isoprostanes, a group of LPO products widely used as biomarkers of oxidative stress, are usually found in human plasma at picomolar concentrations (33, 34) . It is possible that the micromolar concentrations of ascorbylated HNE in human plasma reflect the formation of these vitamin C conjugates in tissues, where intracellular concentrations of ascorbic acid range from 1 to 5 mM, and where HNE can accumulate in membranes at concentrations of 10 M to as high as 5 mM in response to oxidative stress (35) .
Conclusions
The ability of vitamin C to decompose HPODEs to HNE and other toxic LPO products does not necessarily make ascorbic acid a genotoxin (27) . Extrapolating the results obtained from an in vitro system to the in vivo situation is problematic, e.g., because of the inability to mimic the complexity of physiological conditions. Interestingly, we found that GSH has the same capability as ascorbic acid to decompose HPODEs. These data suggest that GSH and ascorbic acid have favorable reduction potentials relative to HPODE. It is likely that numerous other biological reductants behave in a similar manner. Furthermore, based on our data, it can be argued that the ability of vitamin C to decompose HPODEs to LPO products is biologically advantageous. HPODEs are inherently unstable and will degrade in a biological environment like plasma (36) . If vitamin C initiates Fig. 4 . LC͞MS͞MS-MRM analysis of plasma from a healthy 38-year-old male, demonstrating the presence of ascorbylated LPO products other than ascorbylated HNE. Plasma was extracted and analyzed as described in Materials and Methods. the decomposition of lipid hydroperoxides, it should also be available to immediately scavenge the LPO products formed, thereby decreasing the likelihood of the deleterious reactions of these LPO products with other biological targets.
Vitamin C is well known as a hydrogen-donating antioxidant (36, 37) . However, our results reveal a previously unrecognized role of vitamin C, i.e., that of a biological nucleophile. We demonstrate the ability of vitamin C to form Michael adducts with HNE, ONE, and other LPO products in vitro, and show that ascorbylation of LPO products also occurs in vivo, through the detection of the ascorbyl conjugates in human plasma. Because of reaction with vitamin C, the genotoxic ␣,␤-unsaturated aldehyde functionality of the LPO products is no longer available for reaction with 2Ј-deoxyguanosine or other biological targets. The observed results, therefore, may help explain the mechanism by which vitamin C acts as a cancer chemopreventive agent (37) . Our findings also suggest a potential role for vitamin C in other diseases involving oxidative stress, such as atherosclerosis, autoimmune disorders, and Alzheimer's disease, by decreasing or preventing the cytotoxic, genotoxic, and proinflammatory effects of LPO products. Finally, the ascorbyl-LPO product conjugates identified here may serve as novel biomarkers of oxidative stress and may become useful for the assessment of chronic disease risk.
